Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ibex Technologies, a provider of proprietary enzymes for research use, has appointed Bernard Patriacca to its board of directors.
Subscribe to our email newsletter
Mr Patriacca, currently an independent financial consultant, most recently served as vice president, CFO and Treasurer of MacroChem, a US-based publicly-traded specialty pharmaceutical company.
Mr Patriacca has received his MBA in finance/accounting, and his BS/BA in accounting from Northeastern University, Boston, Massachusetts.
Paul Baehr, president and CEO and chairman of Ibex, said: “We are very pleased to have Bernie join our board of directors. His broad prior financial, audit and senior executive experience with companies in or related to our business sector will serve us well as we execute both our near-term and longer term strategic goals.”